Privia Health Reports Strong Q2 2025 Financial Results

Privia Health Group, Inc. has released its financial results for the second quarter of 2025, showcasing robust performance across key financial and operational metrics. The company, a leading physician enablement organization, continues to expand its footprint and enhance its service offerings.

Financial Highlights

For the second quarter ended June 30, 2025, Privia Health reported significant growth in several key financial metrics:

• Total Revenue: $521.2 million, up 23.4% from $422.3 million in Q2 2024.
• Gross Profit: $112.8 million, an increase of 14.8% from $98.3 million in the same period last year.
• Operating Income: $3.3 million, a decrease of 34.6% from $5.1 million in Q2 2024.
• Net Income: $2.7 million, down 22.5% from $3.5 million in the previous year.
• Non-GAAP Adjusted Net Income: $30.6 million, up 30.1% from $23.5 million in Q2 2024.
• Net Income Per Share: $0.02, a decrease of 33.3% from $0.03 in Q2 2024.
• Non-GAAP Adjusted Net Income Per Share: $0.24, an increase of 26.3% from $0.19 in the previous year.

Business and Operational Highlights

Privia Health's operational performance also showed strong growth:

• Implemented Providers: Increased by 13.8% to 5,125 from 4,504 in Q2 2024.
• Practice Collections: $862.9 million, up 18.5% from $728.0 million in the same period last year.
• Adjusted EBITDA: $29.0 million, an increase of 31.6% from $22.0 million in Q2 2024.
• Cash Position: $390.1 million with no debt following a $95 million deployment for the IMS transaction in Arizona.

Strategic Initiatives and Corporate Developments

Privia Health has been active in strategic initiatives to bolster its market position:

• Entered the Arizona market, expanding its geographical footprint.
• Maintained a strong sales and business development pipeline.

Management's Perspective

Management expressed confidence in the company's performance and future prospects. The CEO highlighted the continued strength in same-store growth and new provider additions, which have been key drivers of the company's success.

Future Outlook

Privia Health has raised its full-year 2025 guidance, reflecting its strong performance and positive outlook:

• Practice Collections: Expected to exceed the high end of the range, previously set between $3,150 million and $3,250 million.
• GAAP Revenue: Anticipated to be above the high end of the range, previously set between $1,800 million and $1,900 million.
• Adjusted EBITDA: Projected to be above the high end of the range, previously set between $105 million and $110 million.

SEC Filing: Privia Health Group, Inc. [ PRVA ] - 8-K - Aug. 07, 2025